Co-Enrolment

SWEET is open to participant co-enrolment into the below studies.

Trial	Title	CI
OPTIMA	Optimal Personalised Treatment of early breast cancer using Multi-parameter Analysis	Professor Rob Stein
POETIC-A	Pre-Operative Endocrine Therapy for Individualised Care with Abemaciclib	Professor Stephen Johnston
ATNEC	Axillary management in cT1-3N1M0 breast cancer patients with needle biopsy proven nodal metastases at presentation after neoadjuvant chemotherapy.	Associate Professor Amit Goyal
BCANRAY	Breast CANcer Risk Assessment in Younger women	Dr Sacha Howell
EndoNET	Randomised controlled trial evaluating effectiveness of neoadjuvant endocrine treatment in post-menopausal women (EndoNET)	Professor Michael Douek
PARABLE	Proton beam therapy in patients with breast cancer: evaluating early and late effects	Professor Charlotte Coles
HER2-RADiCAL	(Response ADaptive CAre pLan) – Tailoring treatment for HER2 positive early breast cancer	Professor Iain Macpherson
CHEMOBRAIN	Evaluation of cognitive impairment in breast cancer patients treated with cytotoxic chemotherapy	Dr Laura Kenny
SAFE-DE	Safe de-escalation of chemotherapy for stage 1 breast cancer (SAFE-DE)	Professor Nicholas Turner
SMALL	Open surgery versus minimally invasive vacuum-assisted excision for small screen-detected breast cancer – a phase III randomised multi-centre trial	Mr Stuart McIntosh